The 6th Annual MarketsandMarkets Next-Gen...
Why choose the calScreener™?
Test in difficult conditions
Opaque, viscous or solid media and any kind of cells or complex models
Accurate in-vivo prediction
Mimic the natural environment of your sample
Direct metabolic readout
no additional reagents
Detect metabolic activity as fast as 2 hours
Sterility Testing for Cell and Gene Therapy
The calScreener label-free assay directly monitors the metabolic response in biological systems using bioactivity monitoring. We continuously develop new application areas with external collaborators and our applications team.
The fastest culture-based phenotypic detection method on the market.
Experience fast and phenotypic sterility testing that works on the most complex samples. Biocalorimetry lets you preserve your precious sample and release it to the patient as quickly as possible. The technology in our instrument, the calScreener™, enables small volumes so that you save most of your therapy for the patient. Testing couldn’t be simpler, add your sample into the calVial and leave it to incubate. The calScreener™ measures the metabolic output of your sample in real-time and will alert you at the earliest possible moment if contamination is detected. All you have to do is wait, but not for nearly as long as with other methods.
We are actively recruiting for 3 new roles at Symcel. Find out more on our Careers page.
- Service and Development Engineer
- Quality Assurance and Regulatory Affairs Specialist
- Production Assistant
How does it work?
The calScreener™ allows you to measure the total metabolic activity of your sample, in real-time, at your desired conditions and unlimited run-time that can be set from hours to months.
By directly measuring the heat produced as a result of metabolic processes in the sample, you get an energy output measured in μW, that provides new input not previously possible to see with traditional methods.
In a recent publication in the Journal of...
Symcel Appoints Pia van der Zee as Chief Commercial Officer to Spearhead Growth in Emerging Clinical Markets
[STOCKHOLM, OCTOBER 2023] - Symcel, a leading...